As Europe Prepares for Ambitious Revisions to His Regulatory Framework to Support the Green Deal’s Targets, Key Findings From the Largest European Hydrogen Mobility Initiative Highlight the Role Hydrogen Can Play
14.1.2021 13:03:00 EET | Business Wire | Press release
A flagship project for hydrogen mobility involving nearly 50 organisations at the forefront of the sector has today published its final report detailing the key findings and learnings. The findings are released at a crucial time as the European Green Deal seeks a 90% reduction in transport related emissions by 2050.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005025/en/
Hydrogen Mobility Europe (H2ME) has completed its first phase and compiled a rich dataset since initiating in 2016: 630 hydrogen fuel cell electric vehicles have been deployed in 10 countries and 37 new hydrogen refuelling stations installed in 8 countries, achieving 14.5 million km driven and 147 tonnes of hydrogen dispensed across 68,000 refuelling events. It is the largest European deployment for hydrogen mobility to date and demonstrates the commercial potential to rollout fuel cell electric vehicles (FCEVs) and hydrogen refuelling stations (HRS) for large and small fleets.
Following the conclusion of its initial phase, H2ME recommends national and international incentives that ensure the dispensed cost of low carbon hydrogen is competitive for vehicle operators to create a level playing field with other zero emission vehicles. National, regional, and local policies that ensure continued development of the industry are also recommended. The expansion of hydrogen infrastructure as a result of H2ME, co-funded by the FCH-JU, means more FCEVs now have access to refuelling stations however the limited infrastructure prevents full operational advantages of FCEVs being realised.
Incentives such as purchase grants and tax exemptions will unlock demand from vehicle operators and bring market confidence to vehicle suppliers. Similarly, financial support applied per unit (kg) of hydrogen sold, similar to the feed in tariffs which were applied to stimulate early renewable energy uptake, will lower the price of green hydrogen at the pump. This will enable high utilisation of refuelling stations, which strengthens its business case, demonstrated by clusters of captive fleets with high mileage and heavy-duty cycles as they have significantly lower costs per kilogram of hydrogen.
The second phase of deployment will focus on developing state of the art refuelling stations, increased options for producing green hydrogen, and targeting a wider range of vehicles (from light duty to heavy duty vehicles). The lessons from phase one show that future hydrogen mobility strategies should focus more on high mileage and heavy-duty applications to provide the anchor demand for new installations. This will provide a stronger business case to the HRS operators.
Hydrogen could play a key role in enabling high mileage applications can transition to zero emission as these applications have specific operational needs such as long range and short refuelling time, that can be met by FCEVs. The overall cost of operating FCEVs in these fleets is expected to decrease rapidly in the coming years. For example, an analysis from the ZEFER project found that for high mileages applications such as taxis, and with hydrogen at €7,5/kg, FCEVs can reach parity on a total cost of ownership basis with petrol/diesel hybrids in the next 5 years.
In Denmark three Hyundai ix35 FCEVs are used by the Municipality of Copenhagen for a variety of duties as part of H2ME. They average 120 km travelled per day, with recorded distances up to 500 km in a single day, and have access to three refuelling stations within driving range. Well-to-wheel (WTW) emissions from FCEVs in Denmark are calculated at 20 gCO2e/km, compared to 34 gCO2e/km for a battery electric vehicle, 47 gCO2e/km for a battery electric SUV and 217 gCO2e/km for a diesel comparator. The use of 100% green certified electrolytic hydrogen is key to the low emissions, however FCEVs still achieve significantly lower WTW emissions than diesel or gasoline vehicles even if using hydrogen derived from fossil fuels. Similar analysis conducted in Germany and France found that FCEVs achieve significant emission savings compared to diesel or gasoline vehicles, even if using fossil-derived hydrogen, and can be even more significantly when using low carbon or green hydrogen.
The fuel cell electric vehicles deployed have completed up to 600 km of driving range on a single tank, and prove reliable with over 99% availability over their operational usage since 2016. The confirmation of technology readiness, emerging business cases and customer proposition in the project shows a path towards commercialisation.
With increasing needs for zero emissions mobility solutions to achieve environmental targets, and economics expecting to improve rapidly at scale, there is a strong case to support the commercial rollout for hydrogen mobility.
Bart Biebuyck, Executive Director at Fuel Cells and Hydrogen Joint Undertaking (FCH JU), said: “The first phase of H2ME has demonstrated that light duty hydrogen fuel cell vehicles are performant and nearing market competition with other zero emissions vehicles for high mileage applications, like taxi fleets. In addition, our flagship project was successful in supporting the onset of a European H2 infrastructure for road transport. Today, Europe has a card to play: By integrating these learnings into the heavy duty truck sector, it can capitalise on best practices of vehicles fleets and infrastructure management, making an essential contribution to a green post-Covid recovery of our economy”.
Ben Madden, Director at Element Energy, said: “We are pleased to share the results and findings of the H2ME 1 project. This project would not have been possible without the support from the FCH JU and commitment of all partners involved. Grants to support early stage commercial deployments are a critical step in the path towards commercialisation and will remain one of the key financial tools at the European level in the coming year to develop solutions for zero-emission mobility. Element Energy is very proud to have coordinated this project and to continue supporting the largest hydrogen mobility initiative in Europe.”
Dr Duncan Yellen, Managing Director at ITM Motive, said: “Participation in the H2ME project has been invaluable in providing insights into both the engineering and customer requirements for our future build programme. Thanks to the learning provided here and through other funded projects we are confident in our ability to provide the best possible designs for building the next generation of Hydrogen Refuelling Stations across the UK to match the needs of heavy duty vehicles, high use car fleets and rail.”
Nikolas Iwan, CEO of H2 Mobility, said: “20 of the more than 90 stations in Germany have been built in the H2ME project. We are proud to be partner in the largest European hydrogen mobility initiative. Collaboration is the key to a successful mobility transition, especially in the next phase were rules and regulations have to be set for the light and heavy duty transport sector.”
Anna Margrét Kornelíusdóttir, Project Manager at Icelandic New Energy Ltd, said: "The Nordic countries have long had a faith in clean hydrogen produced from their abundant renewable energy resources. Our governments have made this clear by implementing generous economic incentives and ambitious strategies.
“H2ME has demonstrated the use and reliability of hydrogen and fuel cell technology for passenger vehicles across Europe and proven the feasibility of hydrogen as a transport fuel.
“Amid rising pressure to reach decarbonisation goals, hydrogen technology represents a low carbon and low emission energy solution that can play a vital role in the next steps addressing a transition to clean energy, not only for passenger vehicles, but also heavy-duty trucks, marine vessels and even aviation”.
- Ends -
Notes to Editor
Download the full report here: https://h2me.eu/wp-content/uploads/2021/01/H2ME_Emerging-Conclusions2020.pdf
Image: https://we.tl/t-rvTibkH4Bz
Caption: 37 new hydrogen refuelling stations have been installed in 8 countries as part of the H2ME project
About H2ME
This €170 million demonstration project is co-funded with €67 million from the Fuel Cells and Hydrogen Joint Undertaking (FCH JU), a public-private partnership supporting fuel cell and hydrogen energy technologies in Europe.
Partners include project lead Element Energy, alongside AGA, Air Liquide, AREVA H2GEN, Audi, BOC, BMW, Cenex, City of Copenhagen (Kobenhavns Kommune), Communauté d’Agglomération Sarreguemines Confluence, CNR, Daimler AG, Danish Hydrogen Fuel, EIFER, GNVERT, H2 Mobility Deutschland, Honda, Hydrogen Denmark (Brintbranchen), Hydrogene de France, hySOLUTIONS, Hyundai, Icelandic New Energy Ltd, Intelligent Energy, Islenska Vetnisfelagid (H2 Iceland), Kerkhof, ITM Power, Linde AG, McPhy Energy, Michelin, Nel Hydrogen, Netherlands Ministry of Infrastructure and Water Management (Ministerie Van Infrastructuur en Waterstaat), Nissan, OMV, OPEN ENERGI, Renault, Renault Trucks, SEMITAN, Stedin, STEP, Symbio, Toyota, The University of Manchester, WaterstofNet.
This project has received funding from the Fuel Cells and Hydrogen 2 Joint Undertaking under grant agreement No 671438 & No 700350. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, Hydrogen Europe and Hydrogen Europe research.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005025/en/
Contact information
Declan Shepherd | PR and Social Media Officer at Cenex
Email: Declan.Shepherd@Cenex.co.uk
Website: www.h2me.eu
Twitter: @H2ME_EU
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
